Towards safer thrombolytic therapy
- 1 July 2002
- journal article
- review article
- Published by Elsevier in Seminars in Hematology
- Vol. 39 (3) , 206-216
- https://doi.org/10.1053/shem.2002.34088
Abstract
No abstract availableKeywords
This publication has 87 references indexed in Scilit:
- Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarctionThe Lancet, 2001
- Collaborative Angiographic Patency Trial Of Recombinant Staphylokinase (CAPTORS)American Heart Journal, 2000
- Abciximab in Acute Ischemic StrokeStroke, 2000
- Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trialThe Lancet, 1999
- Abciximab Facilitates the Rate and Extent of ThrombolysisCirculation, 1999
- Hirudin in acute myocardial infarction. Safety report from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9A Trial.Circulation, 1994
- Dissolution of peripheral arterial thrombi by ultrasound.Circulation, 1991
- Outcome of Recent Thromboembolic Occlusions of Limb Arteries Treated with StreptokinaseBMJ, 1970
- THE MECHANISM OF CLOT DISSOLUTION BY PLASMIN*Journal of Clinical Investigation, 1959
- CLINICAL AND EXPERIMENTAL STUDIES ON FIBRINOLYTIC ENZYMESAnnals of the New York Academy of Sciences, 1957